J Korean Neurosurg Soc.  2021 Nov;64(6):950-956. 10.3340/jkns.2021.0004.

A Comprehensive Analysis of the Association of Psoas and Masseter Muscles with Traumatic Brain Injury Using Computed Tomography Anthropometry

• Cho HJ
• Hwang Y
• Yang S
• Kim M

• KMID: 2521985
• DOI: http://doi.org/10.3340/jkns.2021.0004

Abstract

Objective
: Psoas and masseter muscles are known markers of sarcopenia. However, the relative superiority of either muscle as a marker is unclear. Therefore, this study analyzed the two muscles in patients with a prognosis of traumatic brain injury (TBI).
Methods
: Patients with TBI visiting a regional trauma center between January 2017 and December 2018 were selected, and their medical records were reviewed. TBI patients with an abbreviated injury score (AIS) of 4 or 5 were selected. Patients with an AIS of 4 or 5 at the chest, abdomen, and extremity were excluded. Patients with a hospital stay of 1 to 2 days were excluded. Both muscle areas were measured based on the initial computed tomography. The psoas muscle index (PMI) and the masseter muscle index (MMI) were calculated by dividing both muscle areas by height in meters squared (cm²/m²). These muscle parameters along with other medical information were used to analyze mortality and the Glasgow outcome scale (GOS).
Results
: A total of 179 patients, including 147 males (82.1%), were analyzed statistically. The mean patient age was 58.0 years. The mortality rate was 16.8% (30 patients). The mean GOS score was 3.7. Analysis was performed to identify the parameters associated with mortality, which was a qualitative study outcome. The psoas muscle area (16.9 vs. 14.4 cm², p=0.028) and PMI (5.9 vs. 5.1 cm²/m², p=0.004) showed statistical differences between the groups. The PMI was also statistically significant as a risk factor for mortality in logistic regression analysis (p=0.023; odds ratio, 0.715; 95% confidence interval, 0.535–0.954). Quantitative analyses were performed with the GOS scores. Bivariate correlation analysis showed a statistically significant correlation between PMI and GOS scores (correlation coefficient, 0.168; p=0.003). PMI (p=0.004, variation inflation factor 1.001) was significant in multiple regression analysis. The masseter muscle area and MMI did not show significance in the study.
Conclusion
: Larger PMI was associated with statistically significant improved survival and GOS scores, indicating its performance as a superior prognostic marker. Further analyses involving a larger number of patients, additional parameters, and more precise settings would yield a better understanding of sarcopenia and TBI.

Keyword

Traumatic brain injury; Psoas; Masseter muscle; Computed tomography; Prognosis

Figure

• 

  Fig. 1. Flowchart showing the enrollment of patients with traumatic brain injury. CT : computed tomography.

Reference

References

1. Anker SD, Morley JE, von Haehling S. Welcome to the ICD-10 code for sarcopenia. J Cachexia Sarcopenia Muscle. 7:512–514. 2016.

2. Baracos VE. Psoas as a sentinel muscle for sarcopenia: a flawed premise. J Cachexia Sarcopenia Muscle. 8:527–528. 2017.

3. Beaudart C, Biver E, Reginster JY, Rizzoli R, Rolland Y, Bautmans I, et al. Validation of the SarQoL®, a specific health-related quality of life questionnaire for Sarcopenia. J Cachexia Sarcopenia Muscle. 8:238–244. 2017.

4. Bone AE, Hepgul N, Kon S, Maddocks M. Sarcopenia and frailty in chronic respiratory disease. Chron Respir Dis. 14:85–99. 2017.

5. Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 48:16–31. 2019.

6. Cruz-Jentoft AJ, Sayer AA. Sarcopenia. Lancet. 393:2636–2646. 2019.

7. Damluji AA, Rodriguez G, Noel T, Davis L, Dahya V, Tehrani B, et al. Sarcopenia and health-related quality of life in older adults after transcatheter aortic valve replacement. Am Heart J. 224:171–181. 2020.

8. Davis MP, Panikkar R. Sarcopenia associated with chemotherapy and targeted agents for cancer therapy. Ann Palliat Med. 8:86–101. 2019.

9. De Buyser SL, Petrovic M, Taes YE, Toye KR, Kaufman JM, Lapauw B, et al. Validation of the FNIH sarcopenia criteria and SOF frailty index as predictors of long-term mortality in ambulatory older men. Age Ageing. 45:602–608. 2016.

10. Drudi LM, Phung K, Ades M, Zuckerman J, Mullie L, Steinmetz OK, et al. Psoas muscle area predicts all-cause mortality after endovascular and open aortic aneurysm repair. Eur J Vasc Endovasc Surg. 52:764–769. 2016.

11. Gilligan LA, Towbin AJ, Dillman JR, Somasundaram E, Trout AT. Quantification of skeletal muscle mass: sarcopenia as a marker of overall health in children and adults. Pediatr Radiol. 50:455–464. 2020.

12. Hamaguchi Y, Kaido T, Okumura S, Kobayashi A, Hammad A, Tamai Y, et al. Proposal for new diagnostic criteria for low skeletal muscle mass based on computed tomography imaging in Asian adults. Nutrition. 32:1200–1205. 2016.

13. Hu P, Uhlich R, White J, Kerby J, Bosarge P. Sarcopenia measured using masseter area predicts early mortality following severe traumatic brain lijury. J Neurotrauma. 35:2400–2406. 2018.

14. Hwang Y, Lee YH, Cho DH, Kim M, Lee DS, Cho HJ. Applicability of the masseter muscle as a nutritional biomarker. Medicine (Baltimore). 99:e19069. 2020.

15. Lee SJ, Park YJ, Cartmell KB. Sarcopenia in cancer survivors is associated with increased cardiovascular disease risk. Support Care Cancer. 26:2313–2321. 2018.

16. Lindström I, Protto S, Khan N, Hernesniemi J, Sillanpää N, Oksala N. Association of masseter area and radiodensity with three-month survival after proximal anterior circulation occlusion. J Neurointerv Surg. 13:25–29. 2021.

17. Oksala NKJ, Lindström I, Khan N, Pihlajaniemi VJ, Lyytikäinen LP, Pienimäki JP, et al. Pre-operative masseter area is an independent predictor of long-term survival after carotid endarterectomy. Eur J Vasc Endovasc Surg. 57:331–338. 2019.

18. Tanabe C, Reed MJ, Pham TN, Penn K, Bentov I, Kaplan SJ. Association of brain atrophy and masseter sarcopenia with 1-year mortality in older trauma patients. JAMA Surg. 154:716–723. 2019.

19. Toptas M, Yalcin M, Akkoc İ, Demir E, Metin C, Savas Y, et al. The relation between sarcopenia and mortality in patients at intensive care unit. Biomed Res Int. 2018:5263208. 2018.

20. Vellas B, Fielding RA, Bens C, Bernabei R, Cawthon PM, Cederholm T, et al. Implications of ICD-10 for sarcopenia clinical practice and clinical trials: report by the international conference on frailty and sarcopenia research task force. J Frailty Aging. 7:2–9. 2018.

21. Wallace JD, Calvo RY, Lewis PR, Brill JB, Shackford SR, Sise MJ, et al. Sarcopenia as a predictor of mortality in elderly blunt trauma patients: comparing the masseter to the psoas using computed tomography. J Trauma Acute Care Surg. 82:65–72. 2017.